PulseSelect™ Pulse Field Ablation System Precision and Durability: Case Presentation and Discussion-PulseSelect™ Pulse Field Ablation System Precision and Durability: Case Presentation and Discussion

PulseSelect™ Pulse Field Ablation System Precision and Durability: Case Presentation and Discussion

Video Transcription

Video Summary

The session at Rhythm Theater, sponsored by Medtronic, focused on the latest developments in pulse field ablation (PFA) technology, particularly the Pulse Select PFA system—an FDA-approved system in the United States. Dr. Brad Knight and other presenters discussed the precision and durability of this system, highlighting its unique features like a smaller sheath size which reduces vascular complications and facilitates a no-fluoro workflow. Dr. Alana Kutynski shared her extensive experience with the pulse-select catheter, emphasizing its efficiency and the ability to target specific tissues without affecting surrounding areas like epicardial fat and arteries. Dr. Arianna from Sacramento presented comparative data between two PFA systems, Pulse Select and the pentaspline catheter, highlighting comparable outcomes and procedural efficiencies. Differences in serum bilirubin levels and creatinine changes were noted with the pentaspline catheter but resolved spontaneously. Dr. Antonio Moretta shared a case study to illustrate workflow strategies and the importance of precision in PFA to avoid unintended collateral damage. The discussion concluded with a focus on future integration of mapping systems to enhance procedure accuracy and efficiency.

Keywords

Rhythm Theater

Medtronic

pulse field ablation

Pulse Select PFA system

FDA-approved

vascular complications

no-fluoro workflow

catheter efficiency

mapping systems